SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that ...

Insilico Medicine("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), ...

Two UBC Southern Medical Program (SMP) graduates are helping change how cancer survivors receive follow-up care in rural BC, ...

A 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...

Though caution is required when the data haven't been published, it could be a landmark in the drug's journey toward FDA ...

Compass Pathways' Phase 3 COMP-360 data met primary endpoints but disappointed vs analyst expectations. See why investors ...

In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant ...

Psilocybin, the main psychoactive ingredient in magic mushrooms, could alleviate depression for at least five years after ...

Skin grafts genetically engineered from a patient's own cells can heal persistent wounds in people with an extremely painful ...

Discover what clinical trials are, why they're vital for new treatments, and how you can participate in life-changing medical ...